Loading patent…
AssigneeAdtech Co., Ltd.
InventorsJin Dong CHANG, Sung Jin CHO, Won Jae KWAG, Sang Jin KIM
Estimating the term…
The present disclosure relates to an immunodiagnostic device for determining normal and abnormal pregnancy, and more particularly, to an immunodiagnostic device including a multi-binding anti-hCG monoclonal antibody that may recognize Intact hCG and βcf hCG in common, wherein Intact hCG and βcf hCG contained in the sample may be separately detected, including two detection lines and control lines, and the ratio of the color development intensity of βcf hCG to the color development intensity of Intact hCG and βcf hCG (the distribution ratio of βcf hCG) may be numerically quantified to determine the number of weeks of pregnancy, normal pregnancy, and abnormal pregnancy including ectopic pregnancy and blighted ovum accurately and quickly.
An immunodiagnostic device for determining normal and abnormal pregnancy, comprising:
A method for analyzing information required to determine normal and abnormal pregnancy, comprising:
Dependencies are inferred from the claim text.